Ovarian cancer database for patient information
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study collects and organizes information from people who have ovarian cancer. It may help researchers better understand ovarian cancer and how patients are treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have been diagnosed with ovarian cancer
- Have NOT been diagnosed with fallopian tube cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that collects information and samples from people diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It helps doctors better understand these cancers by building a clinical and biological database, which may improve care planning in the future.
This trial is a registry (a database) that collects information from people diagnosed with cervical cancer. It may help researchers better understand cervical cancer and how patients do over time.
This study collects information from people diagnosed with breast cancer to help researchers understand outcomes and treatment patterns. You may or may not receive a new treatment—often it’s about using existing clinical data.
This study collects information from people who have been diagnosed with thyroid cancer. It helps researchers understand thyroid cancer and may support future research or treatments.
This study builds a database of people diagnosed with pancreatic tumors. It may help researchers better understand these cancers by collecting medical information over time.
This study collects information from people with prostate cancer to build a database. Researchers use it to better understand prostate cancer and support future research.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.